News – 1 Nov 2017

SINGAPORE – 1 November 2017 – Enleofen Co-Founder Sebastian Schäfer will be presenting compelling data during the Anti-Fibrotic Drug Development Summit (AFDD) in Boston, USA, from 13-14 November 2017. He will be available throughout the AFDD to discuss Enleofen’s anti-fibrotic drug discovery research.

Schedule an appointment during AFDD

Find out more about the conference: http://afdd-summit.com/